Literature DB >> 21542840

Systemic and neurologic autoimmune disorders associated with seizures or epilepsy.

Angela Vincent1, Peter B Crino.   

Abstract

In this article, we review the incidence and significance of seizures in well-established autoimmune disorders, including multiple sclerosis (MS), diabetes mellitus, celiac disease, thyroid disease, and systemic lupus erythematosus (SLE). The five following presentations discuss the incidence and possible pathogenesis of epilepsies that are found in these well-known autoimmune conditions. There is a large body of evidence describing the clinical presentation of seizures with MS and SLE, and showing that refractory epilepsy can complicate these already challenging disorders. However, the mechanisms involved are complex and generally not well understood. Neurologic syndromes, including seizure disorders, can also be a feature of celiac disease (CD) or subclinical CD, sometimes associated with cerebral calcification. The association between type-1 diabetes mellitus (T1DM) and epilepsy is unclear and requires more definitive epidemiologic analysis, despite the fact that antibodies to glutamic acid decarboxylase may provide a link between the two conditions. The association between thyroid disorders and encephalopathies, often termed Hashimoto's encephalopathy, is well known but the pathogenic significance of antithyroid antibodies in this condition is still debated. In general, the relationships between autoimmune mechanisms and seizures in these conditions are unclear; the seizures are likely to be caused by a variety of mechanisms, including ischemia, neuronal damage, and specific and nonspecific immunity. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2011        PMID: 21542840     DOI: 10.1111/j.1528-1167.2011.03030.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  15 in total

Review 1.  Sex and hormonal influences on seizures and epilepsy.

Authors:  Jana Velíšková; Kara A Desantis
Journal:  Horm Behav       Date:  2012-04-04       Impact factor: 3.587

Review 2.  Diabetes and epilepsy in children and adolescents.

Authors:  M Loredana Marcovecchio; Marianna Immacolata Petrosino; Francesco Chiarelli
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

Review 3.  Inflammatory pathways of seizure disorders.

Authors:  Nicola Marchi; Tiziana Granata; Damir Janigro
Journal:  Trends Neurosci       Date:  2013-12-16       Impact factor: 13.837

4.  Epilepsy as the first presentation of arterial tortuosity syndrome in a young girl: a case report.

Authors:  Sheng Chen; Yuan Hong; Prativa Sherchan; Jian-Min Zhang
Journal:  Turk Neurosurg       Date:  2014       Impact factor: 1.003

Review 5.  Neurological phenotypes for Down syndrome across the life span.

Authors:  Ira T Lott
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

6.  Parental rheumatoid arthritis and childhood epilepsy: A nationwide cohort study.

Authors:  Ane Lilleøre Rom; Chun Sen Wu; Jørn Olsen; Damini Jawaheer; Merete Lund Hetland; Jakob Christensen; Bent Ottesen; Lina Steinrud Mørch
Journal:  Neurology       Date:  2016-11-16       Impact factor: 9.910

7.  The Peptide Network between Tetanus Toxin and Human Proteins Associated with Epilepsy.

Authors:  Guglielmo Lucchese; Jean Pierre Spinosa; Darja Kanduc
Journal:  Epilepsy Res Treat       Date:  2014-06-01

8.  Seizure semiology: an important clinical clue to the diagnosis of autoimmune epilepsy.

Authors:  Rui-Juan Lv; Hai-Tao Ren; Hong-Zhi Guan; Tao Cui; Xiao-Qiu Shao
Journal:  Ann Clin Transl Neurol       Date:  2018-01-22       Impact factor: 4.511

9.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

10.  Risk of epilepsy in patients with systemic lupus erythematosus - a retrospective cohort study.

Authors:  Jeng-Dau Tsai; Cheng-Li Lin; Cheng-Chieh Lin; Fung-Chang Sung; Ko-Huang Lue
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.